Home
/
BICYCLE THERAPEUTICS PLC
/
Financials
/
Quarterly
BICYCLE THERAPEUTICS PLC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BICYCLE THERAPEUTICS PLC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2023
Sep 30, 2023
$0
Nov 2, 2023
Q2
2023
Jun 30, 2023
$0
Aug 3, 2023
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$11.73M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$2.92M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$9.98M
May 1, 2025
Q3
2025
Sep 30, 2024
$2.68M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$9.36M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$19.53M
May 1, 2025
Q3
2024
Sep 30, 2023
$5.35M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$11.40M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$4.90M
May 2, 2024
Q3
2023
Sep 30, 2022
$3.04M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$4.38M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$3.86M
May 4, 2023
Q3
2022
Sep 30, 2021
$4.33M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$1.79M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$1.81M
May 5, 2022
Q3
2021
Sep 30, 2020
$3.84M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$1.57M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$1.13M
May 6, 2021
Q3
2020
Sep 30, 2019
$614.0K
Nov 5, 2020
Q2
2020
Jun 30, 2019
$1.52M
Aug 5, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($59.10M)
Oct 30, 2025
Q3
2025
Jun 30, 2025
($78.95M)
Oct 30, 2025
Q2
2025
Jun 30, 2025
($78.95M)
Aug 8, 2025
Q2
2025
Mar 31, 2025
($60.75M)
Aug 8, 2025
Q3
2025
Mar 31, 2025
($60.75M)
Oct 30, 2025
Q1
2025
Mar 31, 2025
($60.75M)
May 1, 2025
Q3
2025
Sep 30, 2024
($50.80M)
Oct 30, 2025
Q3
2025
Jun 30, 2024
($39.81M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($39.81M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($26.56M)
May 1, 2025
Q3
2025
Mar 31, 2024
($26.56M)
Oct 30, 2025
Q2
2025
Mar 31, 2024
($26.56M)
Aug 8, 2025
Q3
2024
Sep 30, 2023
($49.90M)
Oct 31, 2024
Q3
2024
Jun 30, 2023
($42.60M)
Oct 31, 2024
Q2
2024
Jun 30, 2023
($42.60M)
Aug 6, 2024
Q2
2024
Mar 31, 2023
($39.06M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($39.06M)
May 2, 2024
Q3
2024
Mar 31, 2023
($39.06M)
Oct 31, 2024
Q3
2023
Sep 30, 2022
($28.35M)
Nov 2, 2023
Q3
2023
Jun 30, 2022
($26.83M)
Nov 2, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($65.55M)
Oct 30, 2025
Q2
2025
Jun 30, 2025
($86.60M)
Aug 8, 2025
Q1
2025
Mar 31, 2025
($70.20M)
May 1, 2025
Q3
2025
Sep 30, 2024
($63.85M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($46.65M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($31.72M)
May 1, 2025
Q3
2024
Sep 30, 2023
($50.80M)
Oct 31, 2024
Q2
2024
Jun 30, 2023
($43.11M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($41.80M)
May 2, 2024
Q3
2023
Sep 30, 2022
($29.76M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($27.30M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($27.38M)
May 4, 2023
Q3
2022
Sep 30, 2021
($14.29M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($17.28M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($16.02M)
May 5, 2022
Q3
2021
Sep 30, 2020
($10.68M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($12.58M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($11.64M)
May 6, 2021
Q3
2020
Sep 30, 2019
($10.25M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($7.99M)
Aug 5, 2020